orthopediatrics corp - KIDS

KIDS

Close Chg Chg %
22.22 -0.23 -1.04%

Open Market

21.99

-0.23 (1.04%)

Volume: 16.75K

Last Updated:

Sep 9, 2026, 10:30 AM EDT

Company Overview: orthopediatrics corp - KIDS

KIDS Key Data

Open

$22.04

Day Range

21.96 - 22.23

52 Week Range

14.42 - 26.74

Market Cap

$585.12M

Shares Outstanding

26.11M

Public Float

17.75M

Beta

0.99

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.68

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

228.63K

 

KIDS Performance

1 Week
 
0.00%
 
1 Month
 
-1.58%
 
3 Months
 
25.76%
 
1 Year
 
14.05%
 
5 Years
 
-67.61%
 

KIDS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About orthopediatrics corp - KIDS

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter on August 31, 2006 and is headquartered in Warsaw, IN.

KIDS At a Glance

OrthoPediatrics Corp.
2850 Frontier Drive
Warsaw, Indiana 46582
Phone 1-574-268-6379 Revenue 236.35M
Industry Medical Specialties Net Income -39,648,000.00
Sector Health Technology 2025 Sales Growth 15.445%
Fiscal Year-end 12 / 2026 Employees 602
View SEC Filings

KIDS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.763
Price to Book Ratio 1.286
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -53.427
Enterprise Value to Sales 1.992
Total Debt to Enterprise Value 0.249

KIDS Efficiency

Revenue/Employee 392,604.651
Income Per Employee -65,860.465
Receivables Turnover 4.39
Total Asset Turnover 0.47

KIDS Liquidity

Current Ratio 5.551
Quick Ratio 2.654
Cash Ratio 1.362

KIDS Profitability

Gross Margin 64.512
Operating Margin -12.27
Pretax Margin -16.581
Net Margin -16.775
Return on Assets -7.876
Return on Equity -11.309
Return on Total Capital -8.551
Return on Invested Capital -8.871

KIDS Capital Structure

Total Debt to Total Equity 33.778
Total Debt to Total Capital 25.249
Total Debt to Total Assets 22.382
Long-Term Debt to Equity 32.215
Long-Term Debt to Total Capital 24.081
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Orthopediatrics Corp - KIDS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
122.29M 148.73M 204.73M 236.35M
Sales Growth
+24.72% +21.62% +37.65% +15.45%
Cost of Goods Sold (COGS) incl D&A
44.73M 54.86M 74.89M 83.87M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
13.10M 17.39M 18.76M 20.19M
Depreciation
7.12M 10.24M 10.95M 12.02M
Amortization of Intangibles
5.98M 7.15M 7.81M 8.16M
COGS Growth
+26.62% +22.66% +36.50% +12.00%
Gross Income
77.56M 93.87M 129.84M 152.47M
Gross Income Growth
+23.66% +21.02% +38.32% +17.43%
Gross Profit Margin
+63.43% +63.11% +63.42% +64.51%
2022 2023 2024 2025 5-year trend
SG&A Expense
98.97M 119.63M 159.36M 181.47M
Research & Development
8.01M 10.20M 11.03M 9.10M
Other SG&A
90.96M 109.44M 148.32M 172.37M
SGA Growth
+22.80% +20.88% +33.21% +13.88%
Other Operating Expense
- - - -
-
Unusual Expense
(21.94M) (2.00M) 8.72M 10.24M
EBIT after Unusual Expense
531.00K (23.77M) (38.24M) (39.24M)
Non Operating Income/Expense
(1.80M) 2.46M (1.07M) 6.05M
Non-Operating Interest Income
- - - 198.00K
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 2.42M 2.62M 6.00M
Interest Expense Growth
- - +7.88% +128.77%
-
Gross Interest Expense
- 2.42M 2.62M 6.00M
Interest Capitalized
- - - -
-
Pretax Income
(3.69M) (21.31M) (41.93M) (39.19M)
Pretax Income Growth
+78.78% -477.72% -96.74% +6.54%
Pretax Margin
-3.02% -14.33% -20.48% -16.58%
Income Tax
(4.95M) (338.00K) (4.11M) 460.00K
Income Tax - Current - Domestic
(2.95M) 85.00K (2.52M) 116.00K
Income Tax - Current - Foreign
17.00K 740.00K 525.00K 497.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
(2.02M) (1.16M) (2.11M) (153.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (23.00K)
-
Consolidated Net Income
1.24M (20.97M) (37.82M) (39.65M)
Minority Interest Expense
- - - -
-
Net Income
1.24M (20.97M) (37.82M) (39.65M)
Net Income Growth
+107.60% -1,798.30% -80.33% -4.83%
Net Margin Growth
+1.01% -14.10% -18.47% -16.78%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.24M (20.97M) (37.82M) (39.65M)
Preferred Dividends
- - - -
-
Net Income Available to Common
1.24M (20.97M) (37.82M) (39.65M)
EPS (Basic)
0.0596 -0.925 -1.6389 -1.6901
EPS (Basic) Growth
+107.06% -1,652.01% -77.18% -3.12%
Basic Shares Outstanding
20.70M 22.68M 23.08M 23.46M
EPS (Diluted)
0.059 -0.925 -1.6389 -1.6901
EPS (Diluted) Growth
+106.99% -1,667.80% -77.18% -3.12%
Diluted Shares Outstanding
20.95M 22.68M 23.08M 23.46M
EBITDA
(8.31M) (8.38M) (10.76M) (8.81M)
EBITDA Growth
-15.51% -0.84% -28.40% +18.11%
EBITDA Margin
-6.80% -5.63% -5.26% -3.73%

Snapshot

Average Recommendation BUY Average Target Price 26.667
Number of Ratings 9 Current Quarters Estimate -0.225
FY Report Date 09 / 2026 Current Year's Estimate -1.224
Last Quarter’s Earnings -0.30 Median PE on CY Estimate N/A
Year Ago Earnings -1.69 Next Fiscal Year Estimate -0.824
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate -0.23 -0.25 -1.22 -0.82
High Estimates -0.15 -0.18 -1.08 -0.20
Low Estimate -0.33 -0.30 -1.38 -1.22
Coefficient of Variance -27.81 -18.41 -8.98 -41.25

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 8
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Orthopediatrics Corp in the News